Other congenital malformations of spinal cord

Q17_OTHER_CONGEN_MALFO_SPINAL_CORD

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Q06 Cause of death: ICD-10 — Q06 2 out of 7 registries used, show all original rules.	52
4. Check minimum number of events None	52
5. Include endpoints None	52
6. Filter based on genotype QC (FinnGen only)	47

Control definitions (FinnGen only)

Control exclude: Q17_CONGEN_MALFO_NERVOUS_SYSTEM

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Q0
Name in latin: Aliae malformationes congenitae medullae spinalis

NAME	Q17_OTHER_CONGEN_MALFO_SPINAL_CORD
CONTROL_EXCLUDE	Q17_CONGEN_MALFO_NERVOUS_SYSTEM
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Q06
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Q06
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other congenital malformations of spinal cord based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	561	319	242
Only index persons	443	266	177
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	-	14.91	10.34
Only index persons	22.35	26.14	16.64

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	47	29	18
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	45.96	47.08	44.14

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
52: Matched controls
520

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Q06.8

ICD-10 Finland

Other specified congenital malformations of spinal cord

+∞

27.5

Q06.9

ICD-10 Finland

Congenital malformation of spinal cord, unspecified

+∞

15.3

ABE99

NOMESCO Finland

Other operation for spinal malformation

+∞

8.6

XKC03

NOMESCO Finland

Water cystometry

21.7

8.5

UKC02

NOMESCO Finland

Cystoscopy

8.3

7.8

Q05.9

ICD-10 Finland

Spina bifida, unspecified

+∞

7.5

204

Kela drug reimbursment

Leukemia lymphatica

24.2

7.5

G04AC01, ,

ATC

17.2

6.7

S97

ICPC

Chronic ulcer skin

12.3

6.4

TKC22

NOMESCO Finland

Catheterisation instruction

+∞

6.4

Q06.3

ICD-10 Finland

Other congenital cauda equina malformations

+∞

6.4

G95.0

ICD-10 Finland

Syringomyelia and syringobulbia

+∞

6.4

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

5.0

6.3

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3044640) Blood type and Crossmatch panel - Blood

132

4.01

5.73

2.6

2.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3.99

5.62

2.4

2.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

9.87

3.90

6.1

7.4

24.59

25.40

mmol/l

—

(3003396) Base excess in Arterial blood by calculation

4.71

3.79

10.2

6.4

0.67

2.12

mmol/l

1.71

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

205

3.16

3.73

3.3

2.6

—

(3014007) Fractional oxyhemoglobin in Arterial blood

6.03

2.98

7.1

8.6

96.00

94.65

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

3.82

2.94

4.8

7.1

106.00

104.24

mmol/l

0.49

(3033658) Prothrombin time (PT) actual/Normal

105

2.68

2.82

3.6

5.1

96.86

89.72

0.85

105

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

183

2.51

2.64

2.4

2.9

79.98

75.83

nmol/l

0.37

166

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

6.00

2.62

15.7

6.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

134

2.47

2.53

1.5

1.8

100.34

95.61

pmol/l

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

4.69

2.22

7.5

7.7

0.67

0.87

—

(36304419) Bacteria [Presence] in Urine

117

2.33

2.16

10.5

3.6

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2.48

2.14

1.3

25.75

23.72

nmol/l

0.15

(3011397) Hemoglobin [Presence] in Urine by Test strip

110

2.33

2.11

6.5

3.7

—

(3022621) pH of Urine by Test strip

3.44

2.11

7.3

1.9

—

(3044889) 12 lead EKG panel

265

2.37

2.08

3.1

3.2

—

(3023368) Bacteria identified in Blood by Culture

2.34

1.90

8.6

4.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

308

0.47

1.87

3.7

3.2

29.43

39.97

u/l

1.05

300

(3014051) Protein [Presence] in Urine by Test strip

4.48

1.87

3.4

1.5

—

(3003694) ABO and Rh group [Type] in Blood

149

2.13

1.86

1.2

1.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

3.62

1.80

24.5

7.7

123.17

130.83

g/l

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

143

2.09

1.75

10.2

4.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3.57

1.56

2.2

2.4

—

(3026008) Bacteria identified in Urine by Culture

120

1.92

1.33

11.3

2.6

—

(3020891) Body temperature

2.96

1.31

4.0

6.1

—

(3037467) Urinalysis macro (dipstick) panel - Urine

292

1.93

1.28

10.6

4.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2.80

1.24

29.2

7.9

23.50

24.32

mmol/l

—

(3042936) Bacteria identified in Isolate by Culture

2.19

1.20

5.0

2.2

—

(3000330) Specific gravity of Urine by Test strip

2.65

1.18

2.4

2.0

—

(3045414) Leukocytes [Presence] in Urine

2.65

1.18

1.8

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.52

1.11

7.2

1.5

—

(3019060) Gas panel - Arterial blood

2.52

1.11

15.6

5.0

—

(3012544) pH of Venous blood

2.01

1.05

21.3

9.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.01

1.00

6.2

1.7

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1.81

0.97

2.7

2.2

1.88

2.86

mg/l

1.58

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.07

0.94

31.6

12.4

25.50

25.14

mmol/l

—

(1761868) Lipid panel - Serum or Plasma

135

0.52

0.89

1.3

2.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1.85

0.87

3.0

5.5

24.12

23.11

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1.90

0.87

2.7

3.0

7.39

15.44

umol/l

—

(3020961) Endomysium IgA Ab [Titer] in Serum

0.00

0.81

0.0

1.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.81

0.73

3.4

2.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1.66

0.72

2.5

5.2

2.02

2.03

ug/l

0.00

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.77

0.72

4.3

2.3

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1.87

0.68

8.6

9.0

0.64

1.43

mmol/l

—

(3000494) Fungus identified in Specimen by Culture

1.63

0.63

2.9

1.5

—

(40761535) Cells panel - Urine sediment

1.74

0.63

3.8

4.1

—

(3002256) Pathology report gross observation

1.60

0.62

1.4

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

0.00

0.61

0.0

1.6

—

(3027944) Amphetamines [Presence] in Urine

0.00

0.61

0.0

1.3

—

(3022313) Gas panel - Capillary blood

1.81

0.60

35.3

11.9

—

(3013707) Erythrocyte sedimentation rate by Westergren method

337

0.68

0.60

5.1

4.1

11.62

10.51

mm/h

0.17

315

(3013512) EKG study

109

0.59

0.56

1.3

3.4

—

(40768797) Stomach Pathology biopsy report

1.64

0.51

1.0

1.2

—

(3000991) Gas panel - Venous blood

1.60

0.51

11.1

8.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.49

0.48

3.1

2.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

102

0.64

0.45

5.1

3.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.45

0.44

3.9

2.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.62

0.43

2.4

4.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

111

0.67

0.43

2.6

1.9

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.42

0.0

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.42

0.0

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

0.00

0.42

0.0

1.0

—

4.66

—

(4034850) Laboratory test

0.00

0.42

0.0

6.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

196

1.31

0.36

3.3

2.9

69.96

84.81

ug/l

0.44

186

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

375

0.80

0.25

10.6

11.2

89.82

86.98

ml/min/173m2

0.25

302

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.39

0.24

1.2

1.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.28

0.23

1.6

2.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

113

0.75

0.23

3.0

1.7

—

(3023420) DNA double strand Ab [Units/volume] in Serum

0.00

0.21

0.0

1.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.0

—

0.00

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.0

—

0.00

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.0

—

38.25

—

(3027315) Oxygen [Partial pressure] in Blood

0.00

0.21

0.0

4.5

—

8.60

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.5

—

(3013290) Carbon dioxide [Partial pressure] in Blood

0.00

0.21

0.0

4.5

—

5.17

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

2.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.00

0.21

0.0

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.2

—

1.21

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.2

—

0.00

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.0

—

9.84

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.2

—

2.91

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

0.21

0.0

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.2

—

7.72

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.2

—

3.51

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.00

0.20

0.0

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

217

1.20

0.19

6.5

7.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

149

1.21

0.19

6.6

3.6

—

(21494755) Public health laboratory ask at order entry panel

1.18

0.10

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.15

0.10

5.0

5.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1.12

0.10

1.4

4.8

234.40

236.31

u/l

—

(40758558) Short blood count panel - Blood

134

0.86

0.10

5.3

8.9

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

473

0.93

0.10

10.6

10.0

28.11

26.61

u/l

0.17

460

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

0.77

0.09

1.8

2.3

—

(3037522) Nuclear Ab [Titer] in Serum

1.13

0.08

1.1

1.4

—

590.00

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.84

0.08

2.2

1.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.82

0.07

1.7

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

331

0.91

0.06

3.8

3.5

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

108

1.02

0.00

2.0

2.4

171.09

125.16

u/l

0.28

103

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.7

—

(3045142) Bone marrow Pathology biopsy report

0.00

0.0

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

0.00

0.0

1.3

—

(3051651) Icteric interference index of Serum or Plasma

0.00

0.0

3.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

0.00

0.0

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.0

1.0

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

0.00

0.0

1.3

—

(3037756) Immunofixation for Serum or Plasma

0.00

0.0

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

0.0

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.0

4.0

—

14.67

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

0.0

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

0.00

0.0

3.3

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

0.0

3.0

—

30.50

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(4094501) Cardiovascular stress test using bicycle ergometer

0.00

-0.00

0.0

1.2

—

(3042631) Mycobacterium sp identified in Specimen

0.00

-0.00

0.0

6.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.5

—

33.77

—

(3000012) Reticulocyte production index

0.00

-0.00

0.0

2.5

—

(40768441) Liver Pathology biopsy report

0.00

-0.00

0.0

1.0

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

6.32

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

-0.00

0.0

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

93.88

—

(3028271) Lactate [Moles/volume] in Capillary blood

0.00

-0.00

0.0

5.8

—

1.54

—

(40768804) Tissue Pathology biopsy report

150

1.00

-0.00

2.9

1.9

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

3.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

0.95

-0.00

1.7

1.6

—

(36660697) Celiac disease serology panel - Serum

0.92

-0.00

1.0

1.2

—

(1616796) Gas panel - Central venous blood

0.00

-0.00

0.0

5.8

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3021901) Oxygen saturation in Capillary blood

0.00

-0.00

0.0

9.6

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

0.00

-0.00

0.0

1.5

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.4

—

(40768795) Lymph node Pathology biopsy report

0.00

-0.00

0.0

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

-0.00

0.0

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

0.00

-0.00

0.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

-0.00

0.0

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

0.91

-0.00

1.9

1.7

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

-0.00

0.0

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

1836.20

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

-0.00

0.0

1.1

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

-0.00

0.0

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

-0.00

0.0

6.3

—

(3034770) Mitochondria Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.0

—

(3044927) Protein electrophoresis panel - Urine

0.00

-0.00

0.0

1.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

-0.00

0.0

1.6

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint Q17_OTHER_CONGEN_MALFO_SPINAL_CORD and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have Q17_OTHER_CONGEN_MALFO_SPINAL_CORD.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: Q17_OTHER_CONGEN_MALFO_SPINAL_CORD – Other congenital malformations of spinal cord

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other congenital malformations of spinal cord

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints